Who gets Alzheimer?

['Escucha esta páxina']

¿Quién tien alzheimer?

La enfermedá d'Alzheimer ye un desorde neurodegenerativo progresivu que afecta principalmente a adultos mayores.

El riesgu de desenvolver la enfermedá d'Alzheimer aumenta cola edá, y ye más común en persones mayores de 65 años.

Sicasí, l'Alzheimer d'apaición temprana puede asoceder en persones de 30, 40 y 50 años, anque ye menos común.

La xenética tamién tien un papel nel desenvolvimientu de la enfermedá d'Alzheimer.

Les persones con antecedentes familiares de la enfermedá tienen un riesgu mayor de desenvolvela elles mesmes.

Amás, ciertes mutaciones xenétiques, como'l xen APOE-e4, pueden aumentar la probabilidá de desenvolver Alzheimer.

Otros factores de riesgu pal mal d'Alzheimer inclúin antecedentes de lesión na cabeza, enfermedá cardiovascular y factores de la vida como fumar, obesidá y falta d'exerciciu.

Ye importante tener en cuenta que, anque ciertos factores pueden aumentar el riesgu de desenvolver la enfermedá d'Alzheimer, nun ye una parte normal del envejecimientu, y non toles persones que pasen la edá van desenvolver la enfermedá.

['Referencies']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Kovacs GG: Can Creutzfeldt-Jakob disease unravel the mysteries of Alzheimer? Prion. 2016, 10 (5): 369-376.

Cankurtaran M, Yavuz BB, Cankurtaran ES, Halil M, Ulger Z, Ariogul S: Risk factors and type of dementia: vascular or Alzheimer? Arch Gerontol Geriatr. , 47 (1): 25-34.

Mahami-Oskouei M, Hamidi F, Talebi M, Farhoudi M, Taheraghdam AA, Kazemi T, Sadeghi-Bazargani H, Fallah E: Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer? Parasitol Res. 2016, 115 (8): 3169-74.

Vellas B, Andrieu S, Cantet C, Dartigues JF, Gauthier S: Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer? J Nutr Health Aging. , 11 (4): 338-41.

Bakhtiari S, Moghadam NB, Ehsani M, Mortazavi H, Sabour S, Bakhshi M: Can Salivary Acetylcholinesterase be a Diagnostic Biomarker for Alzheimer? J Clin Diagn Res. 2017, 11 (1): ZC58-ZC60.

['Disclaimer: médicu']

['Esta páxina web tien como únicu propósitu educativu y informativu y nun constitúi un asesoramientu médicu nin un serviciu profesional.']

["La información proporcionada nun tien d'usase pa diagnosticar o tratar un problema de salú o enfermedá, y los que busquen asesoramientu médicu personal tienen de consultar a un médicu llicenciáu."]

['Por favor, note que la rede neuronal que xenera les respuestes a les entrugues ye especialmente inexacta cuando se trata de conteníu numéricu, por casu, el númberu de persones diagnosticáu con una enfermedá específica.']

["Siempre busque'l conseyu del so médicu o otru proveedor calificáu de salú tocantes a una condición médica. Nunca nun ignore'l conseyu médicu profesional o retrase en buscalo por cuenta de daqué que lleó nesta páxina web. Si cree que puede tener una emerxencia médica, llame al 911 o vaya a la sala d'emerxencia más cercana darréu. Nin esta páxina web nin el so usu crean una relación médicu-paciente. Nin BioMedLib nin los sos emplegaos, nin nengún collaborador d'esta páxina web, faen nenguna representación, espreso o implícitu, con respectu a la información proporcionada equí o al so usu."]

["Descargu de derechos d'autor"]

["La Digital Millennium Copyright Act de 1998, 17 U.S.C. § 512 (la DMCA) ufierta recursos a los propietarios de derechos d'autor que crean que'l material qu'apaez n'Internet infrinxe los sos derechos baxo la llei de derechos d'autor d'Estaos Xuníos. "]

["Si crees de bona fe que cualesquier conteníu o material disponible en relación col nuesu sitiu web o servicios infringe los tos drechos d'autor, tu (o'l to axente) puedes unviar una notificación pidiendo que'l conteníu o material seya esaniciáu o l'accesu bloquiáu."]

['Les notificaciones han unviase por escrito por corréu electrónicu (ver la sección "Contactos" pa la dirección de corréu electrónicu).']

["La DMCA riquir que la to notificación d'una supuesta infracción de drechos d'autor incluya la siguiente información: (1) descripción de la obra protexida que ye oxetu de la supuesta infracción; (2) descripción del conteníu supuestamente infractor y información abonda pa dexarnos atopar el conteníu; (3) información de contactu pa ti, incluyendo la to dirección, númberu de teléfonu y dirección de corréu electrónicu; (4) una declaración de bona fe de que tienes la convicción de que'l conteníu de la forma reclamada nun ta autorizáu pol propietariu de drechos d'autor, o'l so axente, o pola operación de cualesquier llei; "]

["5) una declaración, firmada por usté so pena de perxuriu, de que la información contenida na notificación ye esacta y de que ye autorizáu a facer efectivos los drechos d'autor que se consideren violaos;"]

["y (6) una firma física o electrónica del propietariu del copyright o d'una persona autorizada pa actuar nel so nome."]

['Si nun incluyes tola información anterior, pue que la tramitación de la to quexa retrase.']

['Contautu']

['Por favor, unvíenos un corréu electrónicu con cualesquier pregunta o suxerencia.']

Who gets alzheimer?

Alzheimer's disease is a progressive neurodegenerative disorder that primarily affects older adults.

The risk of developing Alzheimer's disease increases with age, and it is most common in people over the age of 65.

However, early-onset Alzheimer's can occur in people in their 30s, 40s, and 50s, although this is less common.

Genetics also play a role in the development of Alzheimer's disease.

People with a family history of the disease are at a higher risk of developing it themselves.

Additionally, certain genetic mutations, such as the APOE-e4 gene, can increase the likelihood of developing Alzheimer's.

Other risk factors for Alzheimer's disease include a history of head injuries, cardiovascular disease, and lifestyle factors such as smoking, obesity, and lack of exercise.

It is important to note that while certain factors can increase the risk of developing Alzheimer's disease, it is not a normal part of aging, and not everyone who ages will develop the disease.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.